Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Ophthalmology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1593556

This article is part of the Research TopicInnovative Advancements in Eye Image Processing for Improved Ophthalmic DiagnosisView all articles

Clinical performance of an interactive platform based on artificial intelligence in ophthalmology: Experience in a third-level reference center

Provisionally accepted
Félix  ArmadáFélix Armadá1*Maria  Capote-DíezMaria Capote-Díez1María del Pino  Cidad-BetegónMaría del Pino Cidad-Betegón1Rosa  María Cordero-RosRosa María Cordero-Ros1Lilian  Martínez-GodoyLilian Martínez-Godoy1Paola  Vázquez-ColomoPaola Vázquez-Colomo1Beatriz  Laín-OlíasBeatriz Laín-Olías2Bruno  Songel-SanchisBruno Songel-Sanchis2Alfonso  Caminos-MelguizoAlfonso Caminos-Melguizo2Inas  Baoud Ould HaddiInas Baoud Ould Haddi2
  • 1University Hospital La Paz, La Paz, Spain
  • 2Zink Medical, Health Market Consulting, Ltd., Valencia, Spain

The final, formatted version of the article will be published soon.

Objective: To assess the diagnostic performance of an interactive platform for ophthalmology in a real-world clinical setting at a tertiary care center. Methods: A prospective, observational, cross-sectional study was conducted on consecutive patients referred by general practitioners to the Ophthalmology Department of a third-level University Hospital. Participants underwent automated ocular evaluation using DORIA (Robotic Ophthalmological Diagnosis through Artificial Intelligence) including the Eyelib™ Robotized scan (MIKAJAKI, Geneva, Switzerland). Results: Of 2,774 referred patients, 2,478 (89.3%) attended their appointments and were examined. Among them, the mean age was 58.5±14.5 years and 1535 (61.9%) were women. Visual acuity loss with 591 (24.2%) patients and fundus examination 421 (17.3%) patients were the most common referral reasons. Based on DORIA results, ophthalmologists concluded that 807 patients (32.6%) required no further ophthalmological care, 858 (34.6%) needed follow-up with a general ophthalmologist, and 341 (13.8%) were referred to primary care. In a detailed assessment of 2478 cases, 1148 (46.3%) were discharged or referred to primary care, while 472 (35.5%) individuals required specialized ophthalmology care. Conclusions: The platform might be considered as a valuable solution to the waiting list issue, reducing specialist interventions, and optimizing healthcare resources. Real-world findings suggest potential cost savings and improved patient management. Further studies are necessary to validate its comparative effectivenessAs a primary goal, the abstract should render the general significance and conceptual advance of the work clearly accessible to a broad readership. References should not be cited in the abstract. Leave the Abstract empty if your article does not require one – please see the “Article types” on every Frontiers journal page for full details.

Keywords: screening, Diagnostic performance, Ophthalmology, artificial intelligence, Interactive platform

Received: 08 Apr 2025; Accepted: 01 Jul 2025.

Copyright: © 2025 Armadá, Capote-Díez, Cidad-Betegón, Cordero-Ros, Martínez-Godoy, Vázquez-Colomo, Laín-Olías, Songel-Sanchis, Caminos-Melguizo and Baoud Ould Haddi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Félix Armadá, University Hospital La Paz, La Paz, Spain

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.